Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti-muscarinic treatment.
To evaluate voiding symptoms and questionnaire score change before and after anti-muscarinic treatment and evaluate the correlation of agreement in patient and doctor satisfaction after treatment. Forty women newly diagnosed with overactive bladder (OAB), attending the urogynecology clinic at Chulalongkorn Hospital during April-June 2011 were recruited. Tolterodine 4 mg orally once daily was given for 4 weeks. A voiding diary and Thai version of the OAB questionnaires eight-item Overactive Bladder awareness tool (OAB-v8), Overactive Bladder Symptoms Score (OABSS) and Overactive Bladder QOL (OABq) were completed before and at the end of treatment. At the end of the trial, self-report patient satisfaction, and doctor satisfaction (according to symptom improvement in the voiding diary) were assessed. Student's t-test and weighted kappa coefficients were used in statistical analysis. Sample size was calculated from an OAB questionnaire pilot study with 20% addition for loss to follow up. All voiding parameters and questionnaire scores (OAB-v8, OABSS and OABq) were improved after treatment. Weighted kappa was only 0.06, between doctor and patient satisfaction. OAB-v8 and OABSS questionnaires can be used as screening and follow-up tools. There is poor agreement between patient and doctor satisfaction. Satisfaction should therefore be measured from the patient's perspective.